Acetic Acid

Acetic Acid

SCHEMBL734741

CC(=O)O.c1cc2cc-2c1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 1/20 0.48
KMO O15229 1/20 0.56
ACMSD Q8TDX5 1/20 0.48
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
PTPN1 P18031 1/20 0.47
MGLL Q99685 1/20 0.46
APP P05067 1/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 1/20 0.46
DHODH Q02127 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
RXRA P19793 2/20 0.44
RXRB P28702 2/20 0.44
KDM4E B2RXH2 2/20 0.44
RXRG P48443 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28772928 1.00 KMO (0.56) KMOACMSDMAPTSMN1; SMN2MEN1
Acetone SCHEMBL18784619 0.91 KMO (0.52) KMOACMSDMAPTSMN1; SMN2MEN1
Pyruvate SCHEMBL27990027 0.89 KMO (0.52) KMOACMSDMAPTSMN1; SMN2MEN1
Bicarbonate SCHEMBL11165825 0.88 KMO (0.61) KMOACMSDMEN1ESR1KMT2A
Acetic Acid SCHEMBL9680398 0.87 KMO (0.45) KMOACMSDMAPTSMN1; SMN2MEN1
Acetamide SCHEMBL1259199 0.86 DHODH (0.48) KMOACMSDMAPTMEN1ESR1
Acetic Acid SCHEMBL27559163 0.85 SMN1; SMN2 (0.64) KMOMAPTSMN1; SMN2MEN1KMT2A
Oxalic Acid SCHEMBL27820733 0.85 KMO (0.58) KMOACMSDMEN1ESR1KMT2A
Acetophenone SCHEMBL27984785 0.83 MAPT (0.68) KMOMAPTSMN1; SMN2MEN1KMT2A
Bicarbonate SCHEMBL9702180 0.82 KMO (0.70) KMOACMSDMEN1ESR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117046304-A Acid-catalyzed cross-linked high-flux acid-resistant nanofiltration membrane and preparation method thereof 宁波日新恒力科技有限公司 2023-11-14 CN claimed
EP-3141284-B1 METHOD OF STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE OREAL (FR) 2019-08-28 EP claimed
EP-2029237-B1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE ORÉAL L (FR) 2016-10-12 EP claimed
US-20160074296-A1 METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN a-HYDROXY ACID DERIVATIVE L'OREAL (FR) 2016-03-17 US claimed
US-20130139844-A1 METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN ¤-HYDROXY ACID DERIVATIVE L'OREAL S.A. (FR) 2013-06-06 US claimed
CN-102822166-A Processes for the preparation of 5 - lipooxygenase activating protein inhibitors and their intermediates GLAXO GROUP LTD 2012-12-12 CN claimed
CN-102070576-B 1-indanone-3-acetic acid compound as well as preparation method and application of 1-indanone-3-acetic acid compound UNIV SICHUAN 2012-11-28 CN claimed
CN-102417497-A Preparation method of optically active 1-indanone-3-acetic acid compound UNIV SICHUAN 2012-04-18 CN claimed
CN-102381961-A 3-phenyl glutaric acid compound, preparation method and purpose thereof UNIV SICHUAN 2012-03-21 CN claimed
US-20110136168-A1 PROCESS FOR PRODUCTION OF NON-NATURAL PROTEIN HAVING ESTER BOND THEREIN RIKEN (JP) 2011-06-09 US claimed
CN-102070576-A 1-indanone-3-acetic acid compound as well as preparation method and application of 1-indanone-3-acetic acid compound UNIV SICHUAN 2011-05-25 CN claimed
US-20100300471-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE L'OREAL S.A. (FR) 2010-12-02 US claimed
CN-1893910-A Cyclic siloxane compositions for active ingredient release GEN ELECTRIC (US) 2007-01-10 CN claimed
WO-2024122393-A1 COMPOSITION FOR IMPROVED STRAIGHTENING OF KERATIN FIBERS L'OREAL (FR) 2024-06-13 WO disclosed
CN-117225384-B Composite material capable of efficiently adsorbing formaldehyde and noble metal as well as preparation method and application thereof 天津得瑞丰凯新材料科技有限公司 2024-02-09 CN disclosed
US-20240010610-A1 COMPOUNDS FOR TREATING SEGMENTAL PROGEROID SYNDROMES PROGELIFE (FR) 2024-01-11 US disclosed
US-4393178-A REACTED WITH IONIZABLE METAL SALT OF AROMATIC COMPOUND IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-07-12 US disclosed
US-4368288-A REACTION PRODUCT WITH IONIZABLE ORGANIC METAL SALT IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1983-01-11 US disclosed
US-4305864-A IONIZABLE METAL SALT NUCLEATING AGENT IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-12-15 US disclosed
EP-0021648-A1 Fast crystallising polyester compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1981-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100300471-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE KRT18, KLK5, HOGA1 ESR1 4517/4885KMO 99/4885ACMSD 819/4885
US-20160074296-A1 METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN a-HYDROXY ACID DERIVATIVE KRT18, HOGA1, CYP27B1 ESR1 4532/4885KMO 126/4885ACMSD 505/4885
US-20130139844-A1 METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN ¤-HYDROXY ACID DERIVATIVE KRT18, HOGA1, CYP27B1 ESR1 4490/4885KMO 146/4885ACMSD 825/4885
US-20240010610-A1 COMPOUNDS FOR TREATING SEGMENTAL PROGEROID SYNDROMES LMNA, LMNB2, LMNB1 ESR1 4842/4885KMO 4214/4885ACMSD 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.